The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx;Der ASA-score als komorbiditätsindex bei mundhöhlen- und mundrachenkarzinomen

Laryngo- Rhino- Otologie

Volumn 85, Issue 2, 2006, Pages 99-104

  Riechelmann, Herbert ^a   Neagos, A ^b   Netzer Yilmaz, U ^a   Gronau, S ^a   Scheithauer, M ^a   Rockemann, M G ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Universitäts HNO Klinik Tirgu Mures   (Germany)

Author keywords

Comorbidity; Cox regression; Oral cavity; Oropharynx; Squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER GRADING; COMORBIDITY; HEAD AND NECK CANCER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MOUTH CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; OROPHARYNX; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33644680324     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870291     Document Type: Article

References (45)

1. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000; 110: 593-602
2. Sabin SL, Rosenfeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999; 78: 578, 581-584
3. Hall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 2000; 22: 317-322
4. Cassia Braga RK, Kowalski LP, Latorre MR. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2003; 129: 219-228
5. Stein M, Herberhold C, Walther EK, Langenberg S. Einfluss von Begleiterkrankungen auf die Prognose von Plattenepithelkarzinomen im Kopf-Hals-Bereich. Laryngorhinootologie 2000; 79: 345-349
6. Borggreven PA, Kuik DJ, Quak JJ, de Bree R, Snow GB, Leemans CR. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 2003; 25: 808-815
7. Singh B, Cordeiro PG, Santamaria E, Shaha AR, Pfister DG, Shah JP. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999; 103: 403-411
8. Extermann M, Bonetti M, Sledge GW, O'Dwyer PJ, Bonomi P, Benson AB III. MAX2 - a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 2004; 40: 1193-1198
9. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity, a critical review of available methods. J Clin Epidemiol 2003; 56: 221-229
10. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002; 112: 1988-1996
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
12. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000; 36: 453-471
13. Paleri V, Wight RG. Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol 2002; 116: 200-205
14. Reid BC, Alberg AJ, Klassen AC, Samet JM, Rozier RG, Garcia I, Winn DM. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001; 92: 2109-2116
15. Reid BC, Alberg AJ, Klassen AC, Koch WM, Samet JM. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck 2001; 23: 985-994
16. Reid BC, Alberg AJ, Klassen AC, Rozier RG, Garcia I, Winn DM, Samet JM. A comparison of three comorbidity indexes in a head and neck cancer population. Oral Oncol 2002; 38: 187-194
17. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997; 107: 1469-1475
18. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387-404
19. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, Har-El G, Lucente FE. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998; 20: 1-7
20. Piccirillo JF. Inclusion of comorbidity in a staging system for head and neck cancer. Oncology (Huntingt) 1995; 9: 831-836
21. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941; 2: 281-284
22. Marx GF, Mateo CV, Orkin LR. Computer analysis of postanesthetic deaths. Anesthesiology 1973; 39: 54-58
23. Nicolai P, Redaelli de Zinis LO, Tomenzoli D, Barezzani MG, Bertoni F, Bignardi M, Antonelli AR. Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 1997; 19: 323-334
24. Popella C, Bodeker R, Glanz H, Kohl S. Mehrfachkarzinome im oberen Aerodigestivtrakt. Teil 1: Mundhöhle und Oropharynx. Laryngorhinootologie 1999; 78: 671-678
25. Day TA, Davis BK, Gillespie MB, Joe JK, Kibbey M, Martin-Harris B, Neville B, Richardson MS, Rosenzweig S, Sharma AK, Smith MM, Stewart S, Stuart RK. Oral cancer treatment. Curr Treat Options Oncol 2003; 4: 27-41
26. Shaha AR, Byers VW, Terz JJ. Society of Surgical Oncology Practice Guidelines. Oropharyngeal and oral cavity cancer surgical practice guidelines. Oncology (Huntingt) 1997; 11: 1211-1212
27. Pasternak LR. ASA practice guidelines for preanesthetic assessment. Int Anesthesiol Clin 2002; 40; 31-46
28. Fleming ID, American Joint Committee on Cancer, National Cancer Institute (U.S.) et al. AJCC cancer staging manual. Philadelphia; Lippincott-Raven, 1997
29. Poppendieck J. Zur Häufigkeit von Mehrfachtumoren im oberen Aerodigestivtrakt. Routinemässige Panendoskopie? HNO 1987; 35: 19-23
30. Dudek J, Wagner G, Grundmann E, Hermanek P. Basisdokumentation für Tumorkranke - Prinzipien und Verschlüsselungsanweisungen für Klinik und Praxis. München, Bern, Wien, New York; Zuckschwerdt Verlag, 1999: 149-153
31. Allal AS, Taussky D, Mach N, Becker M, Bieri S, Dulguerov P. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. Int J Radiat Oncol Biol Phys 2004; 58: 1431-1436
32. Scheithauer M, Dohr D, Riechelmann H. Funktionelle Ergebnisse nach primärer kombinierter perkutaner/interstitielier Strahlentherapie bei Kopf-Hals-Tumoren. Laryngorhinootologie 2002; 81: 712-717
33. Garden AS, Asper JA, Morrison WH, Schechter NR, Glisson BS, Kies MS, Myers JN, Ang KK. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer 2004; 100: 1171-1178
34. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980
35. Riechelmann H. Berufliche Verursachung und Bewertung von Mundhöhlen- und Rachentumoren. Laryngorhinootologie 2002; 81: 573-579
36. Dietz A. Prognostische Faktoren bei primärer Radiochemotherapie von fortgeschrittenen Kopf-Hals-Tumoren unter besonderer Berücksichtigung der Tumor-Zellzykluskomponenten und -Oxygenierung. Laryngorhinootologie 2002; 81: 63-64
37. Wenzel S, Sagowski C, Kehrl W, Aksima T, Metternich FU. Die Kapselruptur metastatisch befallener Lymphknoten als entscheidendes prognostisches Kriterium bei Karzinomen des oberen Aerodigestivtraktes - Hamburger Erfahrungen. Laryngorhinootologie 2003; 82: 707-712
38. Sharp HM, List M, MacCracken E, Stenson K, Stocking C, Siegler M. Patients' priorities among treatment effects in head and neck cancer: evaluation of a new assessment tool. Head Neck 1999; 21: 538-546
39. Medow MA, Weed HG, Schuller DE. Simple predictors of survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002; 128: 1282-1286
40. Larsen R. Anästhesie. München, Wien, Baltimore: Urban & Schwarzenberg, 1987: VII-387
41. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978; 49: 239-243
42. Aronson WL, McAuliffe MS, Miller K. Variability in the American Society of Anesthesiologists Physical Status Classification Scale. AANA J 2003; 71: 265-274
43. Goffi L, Saba V, Ghiselli R, Necozione S, Mattel A, Carle F. Preoperative APACHE II and ASA scores in patients having major general surgical operations: prognostic value and potential clinical applications. Eur J Surg 1999; 165: 730-735
44. Donati A, Ruzzi M, Adrario E, Pelaia P, Coluzzi F, Gabbanelli V, Pietropaoli P. A new and feasible model for predicting operative risk. Br J Anaesth 2004; 93: 393-399
45. Wolters U, Wolf T, Stutzer H, Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77: 217-222